摘要:
A device for sensing biofluid placed on skin with at least one pre-existing pathway includes a first analyte-specific sensor for sensing a first analyte in the biofluid and a volume-reduced pathway between skin and the first analyte-specific sensor configured to allow an advective flow of the biofluid from the at least one pre-existing pathway toward the first analyte-specific sensor. The first analyte-specific sensor does not consume the first analyte. The device further includes an iontophoresis electrode and a counter electrode for bringing the first analyte into the at least one pre-existing pathway. The biofluid may be more than 50% interstitial fluid or more than 50% sweat. The device may also include at least one of a wicking collector, a wicking coupler, or a wicking pump.
摘要:
The present application discloses an iontophoretic device with a contact electrode for detecting placement of the device and/or characteristics of the wearer's tissue.
摘要:
A migration M of a drug ion in a membrane type iontophoresis device for administering the drug ion through a first ion exchange membrane is predicted on the basis of a migration C of the drug ion from the first ion exchange membrane to the outside of the device in the case where a voltage is applied to an electrode by using the device under such a condition that the first ion exchange membrane is not brought into contact with the skin of a living organism and a migration R of the drug ion to a liposome caused by mixing a liposome solution having a predetermined concentration and a drug solution containing a predetermined concentration of the drug ion.
摘要:
Device structure 100 for iontophoresis provides electrode 101 and electrically conductive layer 102. Electrically conductive layer 102 contains active ingredient D and basic water swelling methacrylate copolymer P1 and/or acidic water swelling methacrylate copolymer P2. Electrode 101 and electrically conductive layer 102 are placed into a hollow of backing 103 and electrode terminal 104 is connected to electrode 101 through backing 103. Adhesive layer 105 is set around backing 103, and liner 106 to be removed when using the device, is placed so as to cover the hollow of backing 103.
摘要:
Embodiments of the invention provide patches for the transdermal delivery of iron-containing compositions to an individual suffering from an iron deficiency. Many embodiments provide an iontophoretic patch for the transdermal delivery of a therapeutically effective amount of iron. The patch comprises an electrode and a reservoir containing a composition comprising ionic iron for the delivery of the therapeutically effective amount of iron. Various embodiments provide methods of using embodiments of the iontophoretic patch for delivering a therapeutically effective amount of iron to an individual suffering from one more forms of iron deficiency including iron deficiency anemia. Such methods can be used for treating and/or preventing the iron deficiency. The amount of delivered iron can be adjusted depending upon various treatment parameters such as patient weight and type and amount of iron deficiency.
摘要:
Systems, devices, and methods for evaluating iontophoresis devices. An impedance spectrometer is operable to determine an impedance of an iontophoresis device and a controller configured to perform a comparison of the measured impedance of the iontophoresis device to stored reference data, and to generate a response based in part on the comparison.
摘要:
The present invention provides an iontophoresis device with high administration efficient of a drug. An iontophoresis device, including an active electrode structure including: an electrode to which a positive electrical potential is applied; a drug holding part for holding a drug solution containing positively charged drug ions, the drug holding part being placed on a front side of the electrode; a cellulose-based resin film placed on a front side of the drug holding part or a complex film composed of a cation exchange membrane and a cellulose-based resin film placed on a front side of the cation exchange membrane, the complex film being placed on a front side of the drug holding part, in which the drug ions are administered through the cellulose-based resin film.
摘要:
To provide a transdermal administration device capable of increasing the speed at which a drug is transferred into a skin and the amount of the drug to be transferred into the skin. A transdermal administration device is constituted by: an electrode supplied with a voltage of a first conductivity type; an electrolyte solution holding portion holding an electrolyte solution energized by the electrode; and a bipolar membrane that is placed on the front surface side of the electrolyte solution holding portion, and is composed of a first ion exchange membrane that selectively passes an ion of the first conductivity type and a second ion exchange membrane that selectively passes an ion of a second conductivity type.
摘要:
An iontophoresis device for providing transdermal delivery of one or more therapeutic active agents to a biological interface having an active electrode assembly, a counter electrode assembly, and an inductor electrically coupled to the active and the counter electrode assemblies. The inductor is operable to provide a voltage across at the active and the counter electrode elements in response to an applied varying electromagnetic field.
摘要:
An iontophoresis device which allows excellent transdermal absorption of an anionically chargeable physiologically active substance is provided. The iontophoresis device comprises a cathode (25) and an interface (31) or (32) composed of a cationically chargeable membrane, wherein an anionically chargeable physiologically active substance (drug) (10) is placed between the cathode (25) and the interface (31) or in the interface (32). A wall member (13) with an adhesive layer (12) in the bottom is placed around an absorbent (11), and a support (15) having an opening (14) in the center is placed on the absorbent (11) and the wall member (13). When the device is used, the dissolution liquid for the drug is supplied to the absorbent (11) through the opening (14). The absorbent (11) and the interface (31) or (32) become wet with the dissolution liquid and the drug (10) is activated uniformly.